CVS Health and Oscar Health reported sharply contrasting 2025 results, highlighting how the same inflationary, regulatory and utilization trends hit large diversified incumbents and ACA-focused ...

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

Diversified healthcare company CVS Health (NYSE:CVS) in Q4 CY2025, with sales up 8.2% year on year to $105.7 billion. Its non ...

CVS Health Corp. CVS reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday. Adjusted ...

CVS Health’s CVS third-quarter results included 8% revenue growth and 47% adjusted EPS growth, as margins improved at its medical insurer from a very weak 2024. Those results led to a third ...

Leaving the Affordable Care Act exchange, closing some Oak Street clinics and taking a $5.7 billion charge all have CVS Health on a much better financial path. So good that the healthcare giant ...

Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered ...

In the latest close session, CVS Health (CVS) was down 1.98% at $73.50. The stock trailed the S&P 500, which registered a daily gain of 0.47%. Elsewhere, the Dow gained 0.11%, while the tech-heavy ...

CVS Health Corporation (NYSE:CVS) Q4 2025 Earnings Call Transcript February 10, 2026 CVS Health Corporation beats earnings expectations. Reported EPS is $1.09, expectations were $1. Operator: Hello, ...